Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-03

Clinical Trial Update: A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the maximum tolerated dose of Elesclomol Sodium when given with a fixed dose of Docetaxel and Prednisone in patients with metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)
  • Elesclomol Sodium (elesclomol)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED